The efficient development of tau pathology in tau-seeded 5xFAD/PS19 mice likely explains the high level of atrophy we observed, while synergistic effects of amyloid and tau pathology must also be considered, in line with previously published models [36, 45]. Here, MAPT is linked to amyloidosis.